Protein abundance of clinically relevant drug‐metabolizing enzymes in the human liver and intestine: a comparative analysis in paired tissue specimens
…, J Müller, M Ostrowski, M Kurzawski… - Clinical …, 2018 - Wiley Online Library
This work revises and complements existing findings on the distribution of drug‐metabolizing
enzymes in the first‐pass effect organs. We explored gene expression (quantitative …
enzymes in the first‐pass effect organs. We explored gene expression (quantitative …
[HTML][HTML] Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease
…, M Drozdzik, M Bialecka, M Kurzawski… - BMC medical …, 2010 - Springer
Background Oxidative stress is heavily implicated in the pathogenic process of Parkinson's
disease. Varying capacity to detoxify radical oxygen species through induction of phase II …
disease. Varying capacity to detoxify radical oxygen species through induction of phase II …
Protein abundance of clinically relevant drug transporters in the human liver and intestine: a comparative analysis in paired tissue specimens
…, J Müller, M Ostrowski, M Kurzawski… - Clinical …, 2019 - Wiley Online Library
Bioavailability of orally administered drugs is partly determined by function of drug
transporters in the liver and intestine. Therefore, we explored adenosine triphosphate–binding …
transporters in the liver and intestine. Therefore, we explored adenosine triphosphate–binding …
The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications
M Bialecka, M Kurzawski… - Pharmacogenetics …, 2008 - journals.lww.com
Objectives In this case–control study, we investigated the association of the most common
COMT gene haplotypes (formed by single nucleotide polymorphisms (SNPs): rs6269: A> G; …
COMT gene haplotypes (formed by single nucleotide polymorphisms (SNPs): rs6269: A> G; …
Reduced folate carrier-1 80G> A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis
…, W Gornik, M Kurzawski, M Herczynska - The …, 2007 - nature.com
The folate antagonist methotrexate (MTX) is a drug currently used in the treatment of
rheumatoid arthritis (RA). MTX enters the cells through the reduced folate carrier (RFC-1) and is …
rheumatoid arthritis (RA). MTX enters the cells through the reduced folate carrier (RFC-1) and is …
Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients
M Kurzawski, B Gawrońska-Szklarz… - European journal of …, 2006 - Springer
Objective Eradication of Helicobacter pylori is an important treatment strategy in peptic ulcer
patients. Current regimens of eradication consist of proton pump inhibitor (PPI) and two …
patients. Current regimens of eradication consist of proton pump inhibitor (PPI) and two …
CARD15 variants in patients with sporadic Parkinson's disease
M Bialecka, M Kurzawski, G Klodowska-Duda… - Neuroscience …, 2007 - Elsevier
Recent reports have proven the importance of genetic factors and inflammation in the
pathogenesis of sporadic Parkinson's disease (PD). In the current study, the frequency of CARD15/…
pathogenesis of sporadic Parkinson's disease (PD). In the current study, the frequency of CARD15/…
Association of COMT, MTHFR, and SLC19A1 (RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease
M Bialecka, M Kurzawski, A Roszmann… - Pharmacogenetics …, 2012 - journals.lww.com
Objectives The study was aimed at evaluating the relationships between Hcy, vitamin B12,
and folic acid levels in the blood and cognitive status in PD patients with the genetic …
and folic acid levels in the blood and cognitive status in PD patients with the genetic …
Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs
M Kurzawski, M Droździk - Pharmacogenomics, 2013 - Future Medicine
Allogenic solid organ transplantation has become the routine procedure in patients with end
stage organ disease. Although the transplanted organ compensates deficient body functions…
stage organ disease. Although the transplanted organ compensates deficient body functions…
[HTML][HTML] CYP2C19 polymorphism affects single-dose pharmacokinetics of oral pantoprazole in healthy volunteers
…, E Wyska, M Kurzawski, W Gornik, M Kaldonska… - European journal of …, 2012 - Springer
Objectives Pantoprazole is metabolized by cytochrome P450 2 C19, which shows genetic
polymorphism. The effect of CYP2C19 polymorphism on single-dose pharmacokinetics of oral …
polymorphism. The effect of CYP2C19 polymorphism on single-dose pharmacokinetics of oral …